Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Therapy for Depression With Co-Occurring Panic or Anxiety Symptoms
This study has been completed.
Sponsored by: National Institute of Mental Health (NIMH)
Information provided by: National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier: NCT00051207
  Purpose

This 6-month study, with a 3-month follow up period, will compare the effectiveness of new and traditional psychotherapies for depression with panic or anxiety symptoms.


Condition Intervention Phase
Depression
Anxiety Disorders
Panic Disorder
Behavioral: Interpersonal Psychotherapy (IPT)
Behavioral: IPT for Depression with Co-occurring Panic and Anxiety Symptoms (IPT-PS)
Phase I
Phase II

MedlinePlus related topics: Anxiety Depression Panic Disorder
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title: Interpersonal Psychotherapy for Depression With Co-Occurring Panic and Anxiety Symptoms (IPT-PS)

Further study details as provided by National Institute of Mental Health (NIMH):

Estimated Enrollment: 36
Study Start Date: November 2002
Study Completion Date: August 2005
Detailed Description:

Many depressed patients also experience significant symptoms of panic or anxiety. This study will compare the effectiveness of a new therapy called interpersonal psychotherapy for depression with panic or anxiety symptoms (IPT-PS) with that of traditional interpersonal psychotherapy for depression (IPT).

Participants are randomly assigned to receive up to 24 weeks of treatment with either IPT-PS or traditional IPT. Improvements in interpersonal functioning, quality of life, and symptoms of depression and anxiety will be assessed at the end of therapy and at a 3-month follow-up.

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • DSM-IV diagnosis of major depression with co-existing panic or anxiety symptoms.

Exclusion Criteria:

  • History of manic episode(s). Patients who have had hypomanic episodes in the past will be accepted into the study, provided they meet other admission criteria and are not presenting in a current hypomanic or mixed episode.
  • History of schizophrenia or schizoaffective disorder.
  • Organic affective syndrome.
  • Unspecified functional psychosis.
  • Anorexia nervosa or bulimia nervosa. Patients meeting criteria for an eating disorder not otherwise specified will not be excluded.
  • Chronic drug or alcohol abuse/dependence within the past 2 years. Patients with abuse related to episodes will not be excluded.
  • DSM-IV criteria for borderline or antisocial personality disorder. Patients who meet criteria for other Axis II disorders will not be excluded.
  • Inpatient treatment due to suicide risk or psychotic symptoms.
  • Index episode secondary to the effect of medically prescribed drugs.
  • Significant or untreated medical illness, including cardiovascular disorder, renal or liver disease, epilepsy, untreated hypertension, or unstabilized endocrine disease.
  • Medical illness that would interfere with the best treatment strategy for the potential participant.
  • Current treatment with an antidepressant. Patients on a stable dose of anxiolytics for at least 3 months prior to study participation who are able to maintain this dosage throughout the study will not be excluded.
  • Pregnant and breast-feeding women will be accepted into the study, but will not be prescribed adjunctive medications.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00051207

Locations
United States, Pennsylvania
Western Psychiatric Institute and Clinic - Depression and Manic Depression Program
Pittsburgh, Pennsylvania, United States, 15213
Sponsors and Collaborators
  More Information

Study ID Numbers: R21 MH61948, DSIR AT-AS
Study First Received: January 7, 2003
Last Updated: December 12, 2007
ClinicalTrials.gov Identifier: NCT00051207  
Health Authority: United States: Federal Government

Keywords provided by National Institute of Mental Health (NIMH):
Mood Disorders
Psychotherapy
Comorbidity

Study placed in the following topic categories:
Panic Disorder
Depression
Anxiety Disorders
Mental Disorders
Mood Disorders
Depressive Disorder
Behavioral Symptoms

Additional relevant MeSH terms:
Pathologic Processes
Disease

ClinicalTrials.gov processed this record on January 15, 2009